CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. (Q45984095)
Jump to navigation
Jump to search
scientific article published in November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. |
scientific article published in November 2006 |
Statements
1 reference
CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells. (English)
1 reference
1 reference
Claudia M Kowolik
1 reference
Max S Topp
1 reference
Sergio Gonzalez
1 reference
Timothy Pfeiffer
1 reference
Simon Olivares
1 reference
Nancy Gonzalez
1 reference
Stephen J Forman
1 reference
Michael C Jensen
1 reference
Laurence J N Cooper
1 reference
1 November 2006
1 reference
1 reference
66
1 reference
22
1 reference
10995-11004
1 reference